AR007020A1 - Tratamiento de asma con tnfr-ig - Google Patents
Tratamiento de asma con tnfr-igInfo
- Publication number
- AR007020A1 AR007020A1 ARP970101876A ARP970101876A AR007020A1 AR 007020 A1 AR007020 A1 AR 007020A1 AR P970101876 A ARP970101876 A AR P970101876A AR P970101876 A ARP970101876 A AR P970101876A AR 007020 A1 AR007020 A1 AR 007020A1
- Authority
- AR
- Argentina
- Prior art keywords
- asthma
- treatment
- tnf
- tnfr
- alpha binding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6813—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1684296P | 1996-05-08 | 1996-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007020A1 true AR007020A1 (es) | 1999-10-13 |
Family
ID=21779275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101876A AR007020A1 (es) | 1996-05-08 | 1997-05-06 | Tratamiento de asma con tnfr-ig |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0910413A2 (de) |
| JP (1) | JP2000510113A (de) |
| KR (1) | KR20000010825A (de) |
| CN (1) | CN1233189A (de) |
| AR (1) | AR007020A1 (de) |
| AU (1) | AU725408B2 (de) |
| BR (1) | BR9708928A (de) |
| CA (1) | CA2253557A1 (de) |
| CO (1) | CO4820397A1 (de) |
| HR (1) | HRP970224A2 (de) |
| MA (1) | MA24169A1 (de) |
| PE (1) | PE70698A1 (de) |
| TR (1) | TR199802238T2 (de) |
| WO (1) | WO1997041895A2 (de) |
| ZA (1) | ZA973843B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1044267A2 (de) * | 1997-12-29 | 2000-10-18 | Regeneron Pharmaceuticals, Inc. | Neuartige nulkleinsäure und polypeptide mit homologie zu den tnf-rezeptoren |
| TR200504220T2 (tr) | 1998-12-17 | 2007-04-24 | Biogen Idec Ma Inc. | Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem. |
| US20010021380A1 (en) * | 1999-04-19 | 2001-09-13 | Pluenneke John D. | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| JP4980048B2 (ja) * | 2003-02-28 | 2012-07-18 | アレス トレーディング ソシエテ アノニム | 腫瘍壊死因子結合タンパク質の液体製剤 |
| TWI374935B (en) * | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
| US8338376B2 (en) | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| KR20090071652A (ko) | 2006-10-20 | 2009-07-01 | 바이오겐 아이덱 엠에이 인코포레이티드 | 가용성 림프독소-베타-수용체를 이용한 탈수초성 장애의 치료 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1132471A3 (de) * | 1989-09-12 | 2001-11-28 | F. Hoffmann-La Roche Ag | TNF-bindende Proteine |
| WO1994006476A1 (en) * | 1992-09-15 | 1994-03-31 | Immunex Corporation | Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| US5684222A (en) * | 1993-01-22 | 1997-11-04 | Ontario Cancer Institute | Mutant mouse having a disrupted TNFRp55 |
| CA2119089A1 (en) * | 1993-03-29 | 1994-09-30 | David Banner | Tumor necrosis factor muteins |
| JPH09508140A (ja) * | 1994-07-22 | 1997-08-19 | エフ・ホフマン−ラ ロシュ アーゲー | キメラｔｎｆ結合タンパク質を含有する医薬組成物 |
| US5705364A (en) * | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
| IL116436A (en) * | 1995-12-18 | 2006-12-31 | Yissum Res Dev Co | Fc?Á-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES AND |
-
1997
- 1997-05-02 JP JP09539522A patent/JP2000510113A/ja active Pending
- 1997-05-02 CN CN97194455A patent/CN1233189A/zh active Pending
- 1997-05-02 WO PCT/EP1997/002256 patent/WO1997041895A2/en not_active Application Discontinuation
- 1997-05-02 EP EP97921849A patent/EP0910413A2/de not_active Withdrawn
- 1997-05-02 AU AU27764/97A patent/AU725408B2/en not_active Ceased
- 1997-05-02 BR BR9708928-1A patent/BR9708928A/pt not_active Application Discontinuation
- 1997-05-02 MA MA24590A patent/MA24169A1/fr unknown
- 1997-05-02 KR KR1019980708961A patent/KR20000010825A/ko not_active Application Discontinuation
- 1997-05-02 HR HR60/016,842A patent/HRP970224A2/xx not_active Application Discontinuation
- 1997-05-02 TR TR1998/02238T patent/TR199802238T2/xx unknown
- 1997-05-02 CA CA002253557A patent/CA2253557A1/en not_active Abandoned
- 1997-05-05 PE PE1997000351A patent/PE70698A1/es not_active Application Discontinuation
- 1997-05-05 ZA ZA9703843A patent/ZA973843B/xx unknown
- 1997-05-06 AR ARP970101876A patent/AR007020A1/es not_active Application Discontinuation
- 1997-05-07 CO CO97024335A patent/CO4820397A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2776497A (en) | 1997-11-26 |
| HRP970224A2 (en) | 1998-04-30 |
| AU725408B2 (en) | 2000-10-12 |
| MA24169A1 (fr) | 1997-12-31 |
| PE70698A1 (es) | 1998-11-18 |
| CN1233189A (zh) | 1999-10-27 |
| BR9708928A (pt) | 2000-05-09 |
| WO1997041895A2 (en) | 1997-11-13 |
| EP0910413A2 (de) | 1999-04-28 |
| ZA973843B (en) | 1997-11-10 |
| KR20000010825A (ko) | 2000-02-25 |
| JP2000510113A (ja) | 2000-08-08 |
| CA2253557A1 (en) | 1997-11-13 |
| CO4820397A1 (es) | 1999-07-28 |
| WO1997041895A3 (en) | 1998-03-12 |
| TR199802238T2 (xx) | 1999-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200101481T2 (tr) | Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi. | |
| UA49814C2 (uk) | Композиція, яка містить антиген вірусу папіломи, спосіб лікування цервікального раку, спосіб лікування гострокінцевої кондиломи | |
| TR200100922T2 (tr) | Aktif maddelerin akciğerler yolu ile tatbik edilmesi. | |
| EA199800946A1 (ru) | Концентрированный препарат антител | |
| FI962154A (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
| FI965251A (fi) | Verenkolesterolia alentavia mausteiden, ruoka-ainesten ja ruoka-ainekoostumusten valmistusmenetelmä ja tällaisten mausteiden, ruoka-ainesten ja ruoka-aineiden käyttö | |
| UA52594C2 (uk) | Похідні циклоалканопіридину, суміш їх ізомерів або окремі ізомери, їх солі і n-окиси, спосіб та проміжні сполуки для їх одержання, а також фармацевтична композиція | |
| IL134888A0 (en) | HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING THEM AND THERAPEUTIC USE THEREOF | |
| PL329802A1 (en) | Derivatives of androstene | |
| WO1999058674A3 (en) | Method of inhibiting osteoclast activity | |
| WO2000015205A3 (en) | Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes | |
| UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
| ES2185660T3 (es) | Nuevo uso de dexmedetomidina. | |
| ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
| EE200000054A (et) | Vitamiini D ja kaltsiumit sisaldav ravimkoostis, selle valmistamine ja terapeutiline kasutamine | |
| IT8419308A0 (it) | Procedimento per la preparazione di formulazioni galeniche particolarmente per uso farmaceutico, dietetico, cosmetico e diagnostico. | |
| BR0111869A (pt) | Compostos cìclicos fundidos como moduladores da função do receptor para homÈnio nuclear | |
| AR007020A1 (es) | Tratamiento de asma con tnfr-ig | |
| ES2174054T3 (es) | Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico. | |
| AR007165A1 (es) | Composición farmacéutica para uso oral que contiene diclofenac. | |
| ECSP972104A (es) | Tratamiento de asma con tnfr - ig | |
| ES2016222A4 (es) | Derivados liquidos de grasas naturales y aceites, procedimiento para su elaboracion y utilizacion. | |
| IL129536A0 (en) | Therapeutic and cosmetic compositions their use and method for the preparation thereof | |
| ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
| ES2163001T3 (es) | Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |